NDC 49502-394
Insulin Glargine
Insulin Glargine-yfgn
Insulin Glargine is a Subcutaneous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Mylan Specialty L.p.. The primary component is Insulin Glargine.
| Product ID | 49502-394_a14de887-e390-4d3f-8863-48ca77969e2e |
| NDC | 49502-394 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Insulin Glargine |
| Generic Name | Insulin Glargine-yfgn |
| Dosage Form | Injection, Solution |
| Route of Administration | SUBCUTANEOUS |
| Marketing Start Date | 2021-11-16 |
| Marketing Category | BLA / |
| Application Number | BLA761201 |
| Labeler Name | Mylan Specialty L.P. |
| Substance Name | INSULIN GLARGINE |
| Active Ingredient Strength | 100 [iU]/mL |
| Pharm Classes | Insulin [CS],Insulin Analog [EPC] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2022-12-31 |